Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 20 16:30

Stocks that moved the previous day part 1: Trousse OP, Celest, Maruichi Steel Pipe etc.

Stock Name <Code> Closing Price on the 9th ⇒ Change from the previous day Inspec <6656> 674 +4. Operating profit for the first half turned from a loss of 0.115 billion yen in the first quarter to a profit of 0.001 billion yen. It started to rise but lost momentum. Miroku <7983> 1169 -7624. Performance and dividend forecasts for the fiscal year ending October 24 have been revised downward. Isle <3854> 3000 -145. Operating profit decreased by 5.9% in the first quarter. Daiwa Can <3816> 1105 -89. Operating profit decreased by 29.5% in the first quarter. Tomita Electric <68

Fisco JapanDec 10 06:15

Nxera Pharma Begins Key Insomnia Drug Trial in South Korea

TipRanksDec 5 07:57

Open H, Ship HD, etc. (additional) Rating

Upgrades - bullish Code Stock Name Brokerage Firm Previous After ------------------------------------------------------------- <2413> M3 City "2" "1" <4565> Nexela Pharmacy City "2" "1" <7269> Suzuki JPM "Neutral" "Overweight" Downgrades - bearish Code Stock Name Brokerage Firm Previous After --------------------------

Fisco JapanNov 18 10:46

Rating [security companies rating]

Upgraded - bullish code stock name securities company old change after--------------------------------------------------------------<3110> Nitto Boseki Tokai Tokyo "neutral" "outperform" <9005> Tokyu SBI "hold" "buy" <7269> Suzuki JP Morgan "neutral" "overweight" <2413> M3 City "hold" "buy" <4565> Nexela P City "hold" "

Fisco JapanNov 18 08:26

Express News | Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial With Orx750, a Novel Orexin Receptor 2 (Ox2R) Agonist

BreakingsNov 13 08:01